AI-MIND Consortium to present results at Alzheimer europe
The AI-Mind Consortium is set to make a significant contribution to this year’s Alzheimer Europe Conference taking place in Geneva, Switzerland from 8 to 10 October. With the focus on artificial intelligence (AI) and neurodegenerative disease prevention, AI-Mind’s contributions will highlight the project’s innovative approaches in the field of dementia research aiming at enhancing the understanding of mild cognitive impairment (MCI) and timely dementia risk prediction. The Dementia community will hear from AI-Mind experts about the latest findings and methodologies developed within the project and learn about the use of biomarkers, AI technology, and the role of genetics in Alzheimer’s disease and other forms of cognitive impairment.
AI-Mind Highlights
Throughout the conference, AI-Mind Consortium members will present their latest findings, including presentations on:
- APOE Genotypes and Plasma p-Tau Biomarkers in European MCI Populations: Insights from the AI-MIND Project delivered by Guido Maria Giuffrè from UCSC on 08 October 2024, from 17:15 – 18:30, This presentation will provide a fresh perspective on how certain biomarkers, combined with genetic information, can enhance the early detection of cognitive decline.
- The innovative AI-Mind data collecting framework – a user-centric way of diagnosing mild cognitive impairment delivered by the researchers from OUS on 09 October, from 10:30 – 11:45. The presentation will focus on the innovative AI-Mind data collection approach.
- Associations Between Plasma p-tau217 and Neuropsychological Test Performance in Mild Cognitive Impairment: Baseline Data of the AI-Mind Study by Ana Perez from OUS on 10 October 2024, from 14:00 – 15:15. The presentation will explore the correlation of a given biomarker with a cognitive performance. This work will reveal the potential to serve as a reliable biomarker in the timely detection of Alzheimer’s disease, emphasizing the need for scalable and accessible blood-based biomarkers for diagnosis.
The project coordinator, Ira Haraldsen will also be featured as a key speaker at the plenary session on 10 October from 15:45 to 17:00 dedicated to Brain health and prevention.
Attendees of the event will have the unique opportunity to learn about the latest advancements in dementia risk prediction and prevention from AI-Mind experts. This is a chance to explore how AI is transforming the landscape of neurodegenerative disease research and providing hope for millions affected by cognitive decline.
Fostering collaborations for better outcomes
Participation in the Alzheimer Europe Conference by the AI-Mind project provides an excellent opportunity to ignite collaboration with dementia prevention experts. We hope that these collaborations will contribute significantly to both the European and global Dementia and Alzheimer’s community, with AI-Minds’s research offering the potential to advance clinical practices, enabling timely interventions that may slow or even prevent the onset of dementia.
To stay updated on AI-Mind’s contributions at Alzheimer Europe 2024, and to learn more about the project’s initiatives, visit the AI-Mind website or look up the conference program:
https://www.alzheimer-europe.org/conferences/2024-geneva/detailed-programme
